sec filing
NASDAQ · KPTI
Karyopharm Therapeutics Inc.
Healthcare · Biotechnology
$0.67
Down-$0.02 (-3.07%)
Updated Oct 6, 2026, 10:40 PM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 59.5M
- P/E ratio
- -0.48
- Dividend yield
- 0.00%
- 52-week range
- $0.63 – $10.86
- Volume
- 1.98M
- Avg. volume
- 181.65K
Price performance · KPTI
KPTI price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
KPTI closed at $0.67 after 20 trading sessions, down 61.02% for the selected period.
- Last close
- $0.67
- Period change
- -61.02%
- Period low
- $0.67
- Period high
- $1.88
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $0.8022 | $0.8023 | $0.6259 | $0.6705 | 1.98M |
| Oct 2, 2026 | $0.857 | $0.8938 | $0.7471 | $0.8022 | 2.34M |
| Oct 1, 2026 | $1.19 | $1.20 | $0.8477 | $0.8668 | 2.66M |
| Sep 30, 2026 | $1.26 | $1.27 | $1.18 | $1.22 | 1.75M |
| Sep 29, 2026 | $1.62 | $1.625 | $1.20 | $1.205 | 1.87M |
| Sep 28, 2026 | $1.59 | $1.66 | $1.54 | $1.62 | 331.07K |
| Sep 25, 2026 | $1.73 | $1.77 | $1.565 | $1.62 | 1.47M |
| Sep 24, 2026 | $1.73 | $1.77 | $1.71 | $1.73 | 677.36K |
| Sep 23, 2026 | $1.81 | $1.84 | $1.66 | $1.75 | 957.51K |
| Sep 22, 2026 | $1.87 | $1.92 | $1.78 | $1.82 | 986.9K |
| Sep 21, 2026 | $1.85 | $1.93 | $1.78 | $1.86 | 1.62M |
| Sep 18, 2026 | $1.77 | $1.885 | $1.6701 | $1.88 | 1.9M |
| Sep 17, 2026 | $1.7465 | $1.85 | $1.655 | $1.79 | 1.09M |
| Sep 16, 2026 | $1.54 | $1.72 | $1.54 | $1.70 | 1.35M |
| Sep 15, 2026 | $1.59 | $1.70 | $1.525 | $1.54 | 1.33M |
| Sep 14, 2026 | $1.55 | $1.62 | $1.55 | $1.60 | 991.81K |
| Sep 11, 2026 | $1.50 | $1.61 | $1.24 | $1.61 | 6.74M |
| Sep 10, 2026 | $1.68 | $1.68 | $1.595 | $1.62 | 800.95K |
| Sep 9, 2026 | $1.72 | $1.75 | $1.65 | $1.69 | 772.57K |
| Sep 8, 2026 | $1.77 | $1.79 | $1.70 | $1.72 | 1.01M |
Latest KPTI news
The latest Smart Investors Daily articles mentioning KPTI.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…